首页|开喉剑喷雾剂对支撑喉镜下喉部术后患者咽痛治疗的效果研究

开喉剑喷雾剂对支撑喉镜下喉部术后患者咽痛治疗的效果研究

扫码查看
目的 观察开喉剑喷雾剂对支撑喉镜下行喉部病变手术患者术后咽部疼痛治疗的效果。方法 选取2022年6月至2023年5月前来郑州大学第一附属医院诊治的90例行支撑喉手术的患者,分为观察组及对照组各45例。两组患者术后常规雾化治疗,观察组增加开喉剑喷雾剂的应用。统计分析两组患者治疗后的咽痛程度、咽痛时间、伴随症状如咽干、咽痒、咽异物感等和心理状况。结果 术后观察组疼痛评分低于对照组(P<0。05),观察组疼痛持续时间更短(P<0。05),咽部伴随症状发生率低于对照组(P<0。05),SAS、SDS评分均低于对照组(P<0。05)。结论 开喉剑喷雾剂能够有效的减轻行支撑喉镜手术患者术后咽部疼痛程度及疼痛持续时间,并能够预防咽部伴随症状和改善患者心理状况。
Study on effect of laryngeal sword spray on treatment of sore throat in patients after laryngeal surgery under laryngoscopy
Objective To observe the effect of laryngeal sword spray on the treatment of postoperative pharyngeal pain in patients undergoing laryngeal lesion surgery with laryngoscopy.Methods A total of 90 patients who underwent laryngeal support surgery from June 2022 to May 2023 were divided into observation group and control group,with 45 cases in each group.The two groups were treated with conventional nebulization after surgery,and the observation group increased the application of laryngeal sword spray.The severity of sore throat,sore throat duration,accompanying symptoms such as dry throat,itchy throat,foreign body sensation and psychological status of the two groups were statistically analyzed.Results The pain score of the postoperative observation group was lower than that of the control group(P<0.05),the duration of pain in the observation group was shorter(P<0.05),the incidence of pharyngeal accompanying symptoms was lower than that of the control group(P<0.05),and the scores of SAS and SDS were lower than those of the control group(P<0.05).Conclusion Laryngeal sword spray can effectively reduce the degree and duration of postoperative pharyngeal pain in patients undergoing laryngoscopy,prevent pharyngeal accompanying symptoms and improve patients'psychological status.

Laryngeal sword spraySupporting laryngoscopic surgeryPharyngeal painBenign lesions of the vocal cords

程慧娟、王卫卫、张子梓、徐强

展开 >

郑州大学第一附属医院咽喉头颈外科,郑州 450052

河南省人民医院耳鼻咽喉头颈外科,郑州 450003

开喉剑喷雾剂 支撑喉镜手术 咽部疼痛 声带良性病变

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(13)
  • 16